Trial Profile
Breast Cancer Study of Clinical Efficacy and Safety of Avastin with Paclitaxel in the 1st-taxane-line
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 16 Mar 2020
Price :
$35
*
At a glance
- Drugs Bevacizumab (Primary) ; Paclitaxel (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- Acronyms BRAVE
- 13 Mar 2020 Status changed from recruiting to completed.
- 16 May 2012 New trial record